A β2-microglobulin cleavage variant fibrillates at near-physiological pH

Biochemical and Biophysical Research Communications

Volumn 381, Issue 2, 2009, Pages 187-191

  Corlin, Dorthe B ^a   Johnsen, Christina K ^a   Nissen, Mogens H ^b   Heegaard, Niels H H ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

2 microglobulin; Amyloidosis; Cleavage variant of 2 microglobulin; Dialysis related amyloidosis; Protein folding

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; THIOFLAVINE; ACID;

ARTICLE; CAPILLARY ELECTROPHORESIS; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HEMODIALYSIS PATIENT; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; TURBIDIMETRY; ARTHRITIS; CHEMISTRY; GENETICS; HUMAN; JOINT; METABOLISM; PH; PROTEIN STABILITY;

ACIDS; AMYLOID; ARTHRITIS; BETA 2-MICROGLOBULIN; HUMANS; HYDROGEN-ION CONCENTRATION; JOINTS; PROTEIN STABILITY;

EID: 61849133368     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.041     Document Type: Article

References (40)

1. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8 (1998) 101-106
2. Eakin C.M., Berman A.J., and Miranker A.D. A native to amyloidogenic transition regulated by a backbone trigger. Nat. Struct. Mol. Biol. 13 (2006) 202-208
3. Jahn T.R., Parker M.J., Homans S.W., and Radford S.E. Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat. Struct. Mol. Biol. 13 (2006) 195-201
4. Liu K., Cho H.S., Lashuel H.A., Kelly J.W., and Wemmer D.E. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol. 7 (2000) 754-757
5. Sunde M., and Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50 (1997) 123-159
6. Floege J., and Ehlerding G. Beta-2-microglobulin-associated amyloidosis. Nephron 72 (1996) 9-26
7. Gejyo F., Yamada T., Odani S., Nakagawa Y., Arakawa M., Kunitomo T., Kataoka H., Suzuki M., Hirasawa Y., and Shirahama T. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem. Biophys. Res. Commun. 129 (1985) 701-706
8. Gorevic P.D., Casey T.T., Stone W.J., DiRaimondo C.R., Prelli F.C., and Frangione B. Beta-2 microglobulin is an amyloidogenic protein in man. J. Clin. Invest. 76 (1985) 2425-2429
9. Drueke T.B. Beta-2-microglobulin and amyloidosis. Nephrol. Dial. Transplant. 15 Suppl. 1 (2000) 17-24
10. Heegaard N.H., Roepstorff P., Melberg S.G., and Nissen M.H. Cleaved beta 2-microglobulin partially attains a conformation that has amyloidogenic features. J. Biol. Chem. 277 (2002) 11184-11189
11. Relini A., Canale C., De Stefano S., Rolandi R., Giorgetti S., Stoppini M., Rossi A., Fogolari F., Corazza A., Esposito G., Gliozzi A., and Bellotti V. Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J. Biol. Chem. 281 (2006) 16521-16529
12. Relini A., De Stefano S., Torrassa S., Cavalleri O., Rolandi R., Gliozzi A., Giorgetti S., Raimondi S., Marchese L., Verga L., Rossi A., Stoppini M., and Bellotti V. Heparin strongly enhances the formation of {beta}2-microglobulin amyloid fibrils in the presence of type I collagen. J. Biol. Chem. 283 (2008) 4912-4920
13. Myers S.L., Jones S., Jahn T.R., Morten I.J., Tennent G.A., Hewitt E.W., and Radford S.E. A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH. Biochemistry 45 (2006) 2311-2321
14. Treuhaft P.S., and MCCarty D.J. Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum. 14 (1971) 475-484
15. Kad N.M., Thomson N.H., Smith D.P., Smith D.A., and Radford S.E. Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J. Mol. Biol. 313 (2001) 559-571
16. McParland V.J., Kad N.M., Kalverda A.P., Brown A., Kirwin-Jones P., Hunter M.G., Sunde M., and Radford S.E. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry 39 (2000) 8735-8746
17. Ohishi H., Skinner M., Sato-Araki N., Okuyama T., Gejyo F., Kimura A., Cohen A.S., and Schmid K. Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clin. Chem. 36 (1990) 88-91
18. Clarris B.J., Fraser J.R., Muirden K.D., Malcolm L.P., Holmes M.W., and Rogers K. Stimulation of glycosaminoglycan production and lysosomal activity of human synovial cells in culture by low environmental pH. Ann. Rheum. Dis. 43 (1984) 313-319
19. Becker J.W., and Reeke Jr. G.N. Three-dimensional structure of beta 2-microglobulin. Proc. Natl. Acad. Sci. USA 82 (1985) 4225-4229
20. Corlin D.B., Sen J.W., Ladefoged S., Lund G.B., Nissen M.H., and Heegaard N.H. Quantification of Cleaved {beta}2-Microglobulin in Serum from Patients Undergoing Chronic Hemodialysis. Clin. Chem. 51 (2005) 1177-1184
21. Girndt M., Heisel O., and Kohler H. Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study. Nephrol. Dial. Transplant. 14 (1999) 676-682
22. Lhotta K., Wurzner R., Kronenberg F., Oppermann M., and Konig P. Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int. 53 (1998) 1044-1051
23. Nissen M.H., Plesner T., and M. Rorth Modification of beta 2-microglobulin in serum from patients with small cell carcinoma of the lung--correlation with the clinical course. Clin. Chim. Acta 141 (1984) 41-50
24. Nissen M.H., Bjerrum O.J., Plesner T., Wilken M., and Rorth M. Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease. Clin. Exp. Immunol. 67 (1987) 425-432
25. Nissen M.H., Roepstorff P., Thim L., Dunbar B., and Fothergill J.E. Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s. Eur. J. Biochem. 189 (1990) 423-429
26. Jones S., Manning J., Kad N.M., and Radford S.E. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. J. Mol. Biol. 325 (2003) 249-257
27. Giorgetti S., Stoppini M., Tennent G.A., Relini A., Marchese L., Raimondi S., Monti M., Marini S., Ostergaard O., Heegaard N.H., Pucci P., Esposito G., Merlini G., and Bellotti V. Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis. Protein Sci. 16 (2007) 343-349
28. Nissen M.H., Thim L., and Christensen M. Purification and biochemical characterization of the complete structure of a proteolytically modified beta-2-microglobulin with biological activity. Eur. J. Biochem. 163 (1987) 21-28
29. Nissen M.H., Johansen B., and Bjerrum O.J. A simple method for the preparation and purification of C1 complement cleaved beta 2-microglobulin from human serum. J. Immunol. Methods 205 (1997) 29-33
30. Heegaard N.H., Jorgensen T.J., Cheng L., Schou C., Nissen M.H., and Trapp O. Interconverting conformations of variants of the human amyloidogenic protein beta2-microglobulin quantitatively characterized by dynamic capillary electrophoresis and computer simulation. Anal. Chem. 78 (2006) 3667-3673
31. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
32. LeVine III H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309 (1999) 274-284
33. Jarrett J.T., and Lansbury Jr. P.T. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31 (1992) 12345-12352
34. Heegaard N.H., Jorgensen T.J., Rozlosnik N., Corlin D.B., Pedersen J.S., Tempesta A.G., Roepstorff P., Bauer R., and Nissen M.H. Unfolding, aggregation, and seeded amyloid formation of lysine-58-cleaved beta 2-microglobulin. Biochemistry 44 (2005) 4397-4407
35. Smith D.P., Ciccotosto G.D., Tew D.J., Fodero-Tavoletti M.T., Johanssen T., Masters C.L., Barnham K.J., and Cappai R. Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide. Biochemistry 46 (2007) 2881-2891
36. Krebs M.R., Macphee C.E., Miller A.F., Dunlop I.E., Dobson C.M., and Donald A.M. The formation of spherulites by amyloid fibrils of bovine insulin. Proc. Natl. Acad. Sci. USA 101 (2004) 14420-14424
37. Manuelidis L., Fritch W., and Xi Y.G. Evolution of a strain of CJD that induces BSE-like plaques. Science 277 (1997) 94-98
38. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., Arnsdorf M.F., and Lindquist S.L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289 (2000) 1317-1321
39. Mimmi M.C., Jorgensen T.J., Pettirossi F., Corazza A., Viglino P., Esposito G., De Lorenzi E., Giorgetti S., Pries M., Corlin D.B., Nissen M.H., and Heegaard N.H. Variants of beta-microglobulin cleaved at lysine-58 retain the main conformational features of the native protein but are more conformationally heterogeneous and unstable at physiological temperature. FEBS J. 273 (2006) 2461-2474
40. Gobezie R., Kho A., Krastins B., Sarracino D.A., Thornhill T.S., Chase M., Millett P.J., and Lee D.M. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res. Ther. 9 (2007) R36